文献
J-GLOBAL ID:201802266785415906
整理番号:18A0345301
末期腎疾患の危険性がある糖尿病患者を同定するための改善された臨床試験登録基準【Powered by NICT】
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease
著者 (22件):
Yamanouchi Masayuki
(Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA)
,
Yamanouchi Masayuki
(Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA)
,
Skupien Jan
(Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA)
,
Skupien Jan
(Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA)
,
Skupien Jan
(Department of Metabolic Disease, Jagellonian University Medical College, Krakow, Poland)
,
Niewczas Monika A.
(Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA)
,
Niewczas Monika A.
(Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA)
,
Smiles Adam M.
(Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA)
,
Doria Alessandro
(Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA)
,
Doria Alessandro
(Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA)
,
Stanton Robert C.
(Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA)
,
Stanton Robert C.
(Renal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA)
,
Galecki Andrzej T.
(Institute of Gerontology, University of Michigan Medical School, Ann Arbor, Michigan, USA)
,
Galecki Andrzej T.
(Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan, USA)
,
Duffin Kevin L.
(Lilly Research Laboratories, Eli Lilly & Company Inc. Corporate Center, Indianapolis, Indiana, USA)
,
Pullen Nick
(Pfizer Inc., 610 Main Street, Cambridge, Massachusetts, 02139, USA)
,
Breyer Matthew D.
(Lilly Research Laboratories, Eli Lilly & Company Inc. Corporate Center, Indianapolis, Indiana, USA)
,
Bonventre Joseph V.
(Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA)
,
Bonventre Joseph V.
(Renal Division, Brigham & Women Hospital, Boston, Massachusetts, USA)
,
Warram James H.
(Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA)
,
Krolewski Andrzej S.
(Section on Genetics and Epidemiology, Research Divisions, Joslin Diabetes Center, Boston, Massachusetts, USA)
,
Krolewski Andrzej S.
(Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA)
資料名:
Kidney International
(Kidney International)
巻:
92
号:
1
ページ:
258-266
発行年:
2017年
JST資料番号:
E0559B
ISSN:
0085-2538
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)